The objective is to ensure that providers who bill Federal health care programs do not submit claims for services furnished, ordered or prescribed by an excluded individual or entity. The LEIE is updated monthly with all individuals and entities who have been excluded from participation in Federal health care programs. Providers who bill Medicare, Medicaid, or other Federal health care programs must ensure that they know what individuals or entities are excluded and not bill for their services (e.g., a pharmacy should not bill Medicaid for a drug prescribed by an excluded physician nor for drugs dispensed by an excluded pharmacist).

The dataset here provides the total number of Qualified Health Plan selections by ZIP Code for 37 states for the second Health Insurance Marketplace open enrollment period (November 15, 2014 – February 15, 2015, including additional special enrollment period activity reported through February 22, 2015).

Characteristics of families and children served by Child Care and Development Fund (CCDF)

The 2010 Congressional Report provides results for 70 ANA projects that ended in 2010. The report includes a brief summary of each project visited and an analysis of how ANA funding has impacted Native American communities.

Office of Refugee Resettlement (ORR) Overseas Refugee Arrival Data FY 2000 sorted by country of origin and state of initial resettlement in the United States.

Office of Refugee Resettlement (ORR) Overseas Refugee Arrival Data FY 2010 sorted by country of origin and state of initial resettlement in the United States

Office of Head Start (OHS) Program Fact Sheet provides information on demographics, state allocations, program statistics, and program enrollment history.

The VICP program publishes a summary PDF report with several data tables:

• 
  

  Number of Petitions Filed by Adjudication Categories by Alleged Vaccine, including # of doses distributed (2006-2014)

  
  


• 
  

  Number of Petitions Filed, Compensated, and Dismissed by Alleged Vaccine (cumulative 1998 through 2016)

  
  


• 
  

  Number of Petitions Filed by year (1998-2017)

  
  


• 
  

  Number of Adjudications compensable, dismissed and total (FY1989 - FY2017)

  
  


• 
  

  Awards paid including amounts, attorneys fees, and total outlays (FY1989 - FY2016)

  
  

When it is consistent with the public protection responsibilities of the agency and depending on the nature of the violation, it is the Food and Drug Administration's (FDA's) practice to give individuals and firms an opportunity to take voluntary and prompt corrective action before it initiates an enforcement action. Warning Letters are issued to achieve voluntary compliance and to establish prior notice. The use of Warning Letters and the prior notice policy are based on the expectation that most individuals and firms will voluntarily comply with the law. See http://www.fda.gov/ICECI/ComplianceManuals/RegulatoryProceduresManual/uc... for additional infomation on Warning Letters.

This OIG website contains a list of recently issued advisory opinions and a link to archives of previously issued advisory opinions. In accordance with section 1128D (b) (5) (A) (v) of the Social Security Act and 42 CFR 1008.47 of the Office of Inspector General's (OIG) regulations, advisory opinions issued by the OIG are made available to the general public through this OIG website. One purpose of the advisory opinion process is to provide meaningful advice on the application of the anti-kickback statute and other OIG sanction statutes in specific factual situations. Please note, however, that advisory opinions are binding and may legally be relied upon only by the requestor. Because each opinion will apply legal standards to a set of facts involving certain known persons who provide specific statements about key factual issues, no third parties are bound nor may they legally rely on these advisory opinions.